BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 24188815)

  • 41. Imaging brain amyloid deposition using grating-based differential phase contrast tomography.
    Pinzer BR; Cacquevel M; Modregger P; McDonald SA; Bensadoun JC; Thuering T; Aebischer P; Stampanoni M
    Neuroimage; 2012 Jul; 61(4):1336-46. PubMed ID: 22450300
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Automated detection of amyloid-β-related cortical and subcortical signal changes in a transgenic model of Alzheimer's disease using high-field MRI.
    Teipel SJ; Kaza E; Hadlich S; Bauer A; Brüning T; Plath AS; Krohn M; Scheffler K; Walker LC; Lotze M; Pahnke J
    J Alzheimers Dis; 2011; 23(2):221-37. PubMed ID: 20966552
    [TBL] [Abstract][Full Text] [Related]  

  • 43. IFN-γ Production by amyloid β-specific Th1 cells promotes microglial activation and increases plaque burden in a mouse model of Alzheimer's disease.
    Browne TC; McQuillan K; McManus RM; O'Reilly JA; Mills KH; Lynch MA
    J Immunol; 2013 Mar; 190(5):2241-51. PubMed ID: 23365075
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Longitudinal assessment of Alzheimer's beta-amyloid plaque development in transgenic mice monitored by in vivo magnetic resonance microimaging.
    Braakman N; Matysik J; van Duinen SG; Verbeek F; Schliebs R; de Groot HJ; Alia A
    J Magn Reson Imaging; 2006 Sep; 24(3):530-6. PubMed ID: 16892201
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Application of a non-linear image registration algorithm to quantitative analysis of T2 relaxation time in transgenic mouse models of AD pathology.
    Falangola MF; Ardekani BA; Lee SP; Babb JS; Bogart A; Dyakin VV; Nixon R; Duff K; Helpern JA
    J Neurosci Methods; 2005 May; 144(1):91-7. PubMed ID: 15848243
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Curcumin-conjugated magnetic nanoparticles for detecting amyloid plaques in Alzheimer's disease mice using magnetic resonance imaging (MRI).
    Cheng KK; Chan PS; Fan S; Kwan SM; Yeung KL; Wáng YX; Chow AH; Wu EX; Baum L
    Biomaterials; 2015 Mar; 44():155-72. PubMed ID: 25617135
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In vivo magnetic resonance microimaging of individual amyloid plaques in Alzheimer's transgenic mice.
    Jack CR; Wengenack TM; Reyes DA; Garwood M; Curran GL; Borowski BJ; Lin J; Preboske GM; Holasek SS; Adriany G; Poduslo JF
    J Neurosci; 2005 Oct; 25(43):10041-8. PubMed ID: 16251453
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fast in vivo imaging of amyloid plaques using μ-MRI Gd-staining combined with ultrasound-induced blood-brain barrier opening.
    Santin MD; Debeir T; Bridal SL; Rooney T; Dhenain M
    Neuroimage; 2013 Oct; 79():288-94. PubMed ID: 23660031
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identification of amyloid plaques in retinas from Alzheimer's patients and noninvasive in vivo optical imaging of retinal plaques in a mouse model.
    Koronyo-Hamaoui M; Koronyo Y; Ljubimov AV; Miller CA; Ko MK; Black KL; Schwartz M; Farkas DL
    Neuroimage; 2011 Jan; 54 Suppl 1():S204-17. PubMed ID: 20550967
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Diffusion kurtosis imaging allows the early detection and longitudinal follow-up of amyloid-β-induced pathology.
    Praet J; Manyakov NV; Muchene L; Mai Z; Terzopoulos V; de Backer S; Torremans A; Guns PJ; Van De Casteele T; Bottelbergs A; Van Broeck B; Sijbers J; Smeets D; Shkedy Z; Bijnens L; Pemberton DJ; Schmidt ME; Van der Linden A; Verhoye M
    Alzheimers Res Ther; 2018 Jan; 10(1):1. PubMed ID: 29370870
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Contrast-enhanced MR microscopy of amyloid plaques in five mouse models of amyloidosis and in human Alzheimer's disease brains.
    Dudeffant C; Vandesquille M; Herbert K; Garin CM; Alves S; Blanchard V; Comoy EE; Petit F; Dhenain M
    Sci Rep; 2017 Jul; 7(1):4955. PubMed ID: 28694463
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Gradient-echo and CRAZED imaging for minute detection of Alzheimer plaques in an APPV717I x ADAM10-dn mouse model.
    Faber C; Zahneisen B; Tippmann F; Schroeder A; Fahrenholz F
    Magn Reson Med; 2007 Apr; 57(4):696-703. PubMed ID: 17390347
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A non-toxic ligand for voxel-based MRI analysis of plaques in AD transgenic mice.
    Sigurdsson EM; Wadghiri YZ; Mosconi L; Blind JA; Knudsen E; Asuni A; Scholtzova H; Tsui WH; Li Y; Sadowski M; Turnbull DH; de Leon MJ; Wisniewski T
    Neurobiol Aging; 2008 Jun; 29(6):836-47. PubMed ID: 17291630
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Seizure susceptibility in the APP/PS1 mouse model of Alzheimer's disease and relationship with amyloid β plaques.
    Reyes-Marin KE; Nuñez A
    Brain Res; 2017 Dec; 1677():93-100. PubMed ID: 28963050
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In vivo multi-parametric manganese-enhanced MRI for detecting amyloid plaques in rodent models of Alzheimer's disease.
    Kim E; Di Censo D; Baraldo M; Simmons C; Rosa I; Randall K; Ballard C; Dickie BR; Williams SCR; Killick R; Cash D
    Sci Rep; 2021 Jun; 11(1):12419. PubMed ID: 34127752
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Histological co-localization of iron in Abeta plaques of PS/APP transgenic mice.
    Falangola MF; Lee SP; Nixon RA; Duff K; Helpern JA
    Neurochem Res; 2005 Feb; 30(2):201-5. PubMed ID: 15895823
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ultra-High Field MRI in Alzheimer's Disease: Effective Transverse Relaxation Rate and Quantitative Susceptibility Mapping of Human Brain In Vivo and Ex Vivo compared to Histology.
    Tuzzi E; Balla DZ; Loureiro JRA; Neumann M; Laske C; Pohmann R; Preische O; Scheffler K; Hagberg GE
    J Alzheimers Dis; 2020; 73(4):1481-1499. PubMed ID: 31958079
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Detection of amyloid plaques in mouse models of Alzheimer's disease by magnetic resonance imaging.
    Zhang J; Yarowsky P; Gordon MN; Di Carlo G; Munireddy S; van Zijl PC; Mori S
    Magn Reson Med; 2004 Mar; 51(3):452-7. PubMed ID: 15004784
    [TBL] [Abstract][Full Text] [Related]  

  • 59. SPION-enhanced magnetic resonance imaging of Alzheimer's disease plaques in AβPP/PS-1 transgenic mouse brain.
    Sillerud LO; Solberg NO; Chamberlain R; Orlando RA; Heidrich JE; Brown DC; Brady CI; Vander Jagt TA; Garwood M; Vander Jagt DL
    J Alzheimers Dis; 2013; 34(2):349-65. PubMed ID: 23229079
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Magnetic resonance imaging for monitoring therapeutic response in a transgenic mouse model of Alzheimer's disease using voxel-based analysis of amyloid plaques.
    Kim JH; Ha TL; Im GH; Yang J; Seo SW; Chung JJ; Chae SY; Lee IS; Lee JH
    Neuroreport; 2014 Mar; 25(4):211-8. PubMed ID: 24518227
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.